Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis

BACKGROUND: There are many reports of the anti-tumour effects of exogenous adenosine in gastrointestinal tumours. Gemcitabine, a first line agent for patients with poor performance status, and adenosine have structural similarities. For these reasons, it is worth exploring the therapeutic efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dongqin, Zhang, Qi, Ma, Yunfang, Che, Zhihui, Zhang, Wenli, Wu, Mengmeng, Wu, Lijun, Liu, Fuchen, Chu, Yiwei, Xu, Wei, McGrath, Mary, Song, Chunhua, Liu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796568/
https://www.ncbi.nlm.nih.gov/pubmed/31495718
http://dx.doi.org/10.1016/j.ebiom.2019.08.068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796568/
https://www.ncbi.nlm.nih.gov/pubmed/31495718
http://dx.doi.org/10.1016/j.ebiom.2019.08.068

Ejemplares similares